Pharmacokinetics, Safety, and Tolerability of TMC207 in Subjects With Moderately Impaired Hepatic Function.

Trial Profile

Pharmacokinetics, Safety, and Tolerability of TMC207 in Subjects With Moderately Impaired Hepatic Function.

Completed
Phase of Trial: Phase I

Latest Information Update: 19 Dec 2012

At a glance

  • Drugs Bedaquiline (Primary)
  • Indications Tuberculosis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 11 Dec 2012 Actual initiation date changed from Feb 2010 to Jan 2010 as reported by ClinicalTrials.gov.
    • 27 Jan 2011 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
    • 27 Jan 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top